Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Amphenol Q1 Earnings Top Estimates, Lifts Full-year View - Update

RELATED NEWS
Trade APH now with 

Amphenol Corp. (APH: Quote) reported Wednesday a decline in first-quarter profit, while earnings per share increased and beat Street expectations. The fiber-optic cable maker also issued guidance for the second quarter and lifted its full-year 2012 view.

Adam Norwitt, president and chief executive officer of the company said, "On a year-over-year basis, strength in automotive, commercial aerospace, broadband communications and industrial markets offset declines in the defense and wireless markets, reflecting the significant benefits of the Company's diversity."

In the first quarter, net income attributable to the company declined to $126.56 million from $127.96 million in the previous year.

On a per share basis, earnings were $0.77, up from $0.72 per share, on lower share count. On average, 12 analysts polled by Thomson Reuters expected the company to earn $0.76 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter grew 4 percent to $981.6 million from $940.59 million in the prior year, which also exceeded analysts' estimate of $972.14 million. Currency translation decreased sales by around $4 million.

Looking ahead to the second quarter, the company expects earnings per share to be in the range of $0.82 to $0.85. Revenues are expected to be between $1.04 billion and $1.055 billion. Analysts expect the company to earn $0.83 per share, on revenues of $1.03 billion for the second quarter.

For the full year 2012, earnings per share are now expected to be in the range of $3.30 to $3.38, up from the prior forecast of $3.23 to $3.34 per share. Revenues are anticipated to be between $4.105 billion and $4.190 billion, compared to the prior outlook of $4.050 billion to $4.150 billion.

Analysts are looking for earnings of $3.33 per share, on revenues of $4.16 billion for the year.

APH is currently trading at $57.56, down $2.39 or 3.98 percent, on a volume of 610 thousand shares on the Nasdaq.

Register
To receive FREE breaking news email alerts for Amphenol Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.